The University of Chicago Header Logo

Connection

Joseph Caprini to Humans

Back to Details
This is a "connection" page, showing publications Joseph Caprini has written about Humans.
Joseph Caprini
Connection Strength
1.208
Humans
  1. Dissecting the rationale for thromboprophylaxis in challenging surgical cases. J Thromb Haemost. 2024 Mar; 22(3):613-619.
    View in: PubMed
    Score: 0.030
  2. A New Chapter Regarding Thrombosis Risk Assessment in Total Joint Replacement Patients. Thromb Haemost. 2024 Mar; 124(3):236-238.
    View in: PubMed
    Score: 0.029
  3. The Thresholds of Caprini Score Associated With Increased Risk of Venous Thromboembolism Across Different Specialties: A Systematic Review. Ann Surg. 2023 06 01; 277(6):929-937.
    View in: PubMed
    Score: 0.028
  4. Using the Caprini Risk Score to Increase VTE Awareness in the Community: The Know Your Score Project. Clin Appl Thromb Hemost. 2022 Jan-Dec; 28:10760296221107020.
    View in: PubMed
    Score: 0.026
  5. The original and modified Caprini score equally predicts venous thromboembolism in COVID-19 patients. J Vasc Surg Venous Lymphat Disord. 2021 11; 9(6):1371-1381.e4.
    View in: PubMed
    Score: 0.025
  6. Comparison of a nonpneumatic device to four currently available intermittent pneumatic compression devices on common femoral blood flow dynamics. J Vasc Surg Venous Lymphat Disord. 2021 09; 9(5):1241-1247.
    View in: PubMed
    Score: 0.025
  7. Identification of "Never Events" After Orthopaedic Trauma. J Orthop Trauma. 2020 08; 34(8):421-423.
    View in: PubMed
    Score: 0.024
  8. Venous thromboembolism and transfusion after major abdominopelvic surgery. Surgery. 2020 06; 167(6):1025.
    View in: PubMed
    Score: 0.023
  9. Risk Assessment After Orthopaedic Trauma: Coming of Age. J Orthop Trauma. 2019 06; 33(6):275.
    View in: PubMed
    Score: 0.022
  10. Venous thromboembolism prophylaxis using the Caprini score. Dis Mon. 2019 Aug; 65(8):249-298.
    View in: PubMed
    Score: 0.021
  11. Implementation and Validation of the 2013 Caprini Score for Risk Stratification of Arthroplasty Patients in the Prevention of Venous Thrombosis. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619838066.
    View in: PubMed
    Score: 0.021
  12. Completion of the Updated Caprini Risk Assessment Model (2013 Version). Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619838052.
    View in: PubMed
    Score: 0.021
  13. Regarding "Risk factors for presence and severity of pulmonary embolism in patients with deep venous thrombosis". J Vasc Surg Venous Lymphat Disord. 2018 07; 6(4):559-560.
    View in: PubMed
    Score: 0.020
  14. Venous Thromboembolism Risk Stratification: The Missing Link in Hospitalized Patients. J Atheroscler Thromb. 2018 Nov 01; 25(11):1087-1088.
    View in: PubMed
    Score: 0.020
  15. Letter to the Editor on "Correlation of the Caprini Score and Venous Thromboembolism Incidence Following Primary Total Joint Arthroplasty-Results of a Single-Institution Protocol". J Arthroplasty. 2018 08; 33(8):2697-2698.
    View in: PubMed
    Score: 0.020
  16. Risk assessment as a guide for the prevention of cancer-associated thromboembolism. Int Angiol. 2018 Aug; 37(4):269-276.
    View in: PubMed
    Score: 0.020
  17. Venous thromboembolism controversies. Dis Mon. 2018 09; 64(9):408-444.
    View in: PubMed
    Score: 0.020
  18. Validation of a Patient-Completed Caprini Risk Assessment Tool for Spanish, Arabic, and Polish Speakers. Clin Appl Thromb Hemost. 2018 Apr; 24(3):502-512.
    View in: PubMed
    Score: 0.020
  19. Cancer-associated thrombosis. Dis Mon. 2016 May; 62(5):121-58.
    View in: PubMed
    Score: 0.018
  20. Commentary on 'Adjustable Velcro Compression Devices are More Effective than Inelastic Bandages in Reducing Venous Edema in the Initial Treatment Phase: A Randomized Controlled Trial'. Eur J Vasc Endovasc Surg. 2015 Sep; 50(3):375.
    View in: PubMed
    Score: 0.017
  21. Balancing the risk of complications in foot and ankle surgical patients taking antithrombotic medication. Foot Ankle Spec. 2014 Dec; 7(6):507-14.
    View in: PubMed
    Score: 0.016
  22. Current state of knowledge on oral anticoagulant reversal using procoagulant factors. Ann Pharmacother. 2013 Jun; 47(6):841-55.
    View in: PubMed
    Score: 0.014
  23. Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding. Thromb Haemost. 2012 Jul; 108(1):183-90.
    View in: PubMed
    Score: 0.013
  24. Validation of Venous Clinical Severity Score (VCSS) with other venous severity assessment tools from the American Venous Forum, National Venous Screening Program. J Vasc Surg. 2011 Dec; 54(6 Suppl):2S-9S.
    View in: PubMed
    Score: 0.013
  25. Identification of patient venous thromboembolism risk across the continuum of care. Clin Appl Thromb Hemost. 2011 Nov-Dec; 17(6):590-9.
    View in: PubMed
    Score: 0.013
  26. Critical issues in deep vein thrombosis prevention. J Vasc Surg. 2010 Nov; 52(5 Suppl):64S-65S.
    View in: PubMed
    Score: 0.012
  27. Individual risk assessment is the best strategy for thromboembolic prophylaxis. Dis Mon. 2010 Oct; 56(10):552-9.
    View in: PubMed
    Score: 0.012
  28. Risk assessment as a guide to thrombosis prophylaxis. Curr Opin Pulm Med. 2010 Sep; 16(5):448-52.
    View in: PubMed
    Score: 0.012
  29. The value of inelastic compression. Phlebology. 2010 Jun; 25(3):105-6.
    View in: PubMed
    Score: 0.012
  30. Stockings or no stockings: that is the question. Ann Surg. 2010 Mar; 251(3):397-8.
    View in: PubMed
    Score: 0.012
  31. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010 Feb; 251(2):344-50.
    View in: PubMed
    Score: 0.011
  32. Venous thromboembolism in surgery--a preventable complication. Introduction. Am J Surg. 2010 Jan; 199(1 Suppl):S1-2.
    View in: PubMed
    Score: 0.011
  33. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg. 2010 Jan; 199(1 Suppl):S3-10.
    View in: PubMed
    Score: 0.011
  34. Mechanical methods for thrombosis prophylaxis. Clin Appl Thromb Hemost. 2010 Dec; 16(6):668-73.
    View in: PubMed
    Score: 0.011
  35. Intermittent pneumatic compression and pharmacologic thrombosis prophylaxis. Curr Opin Pulm Med. 2009 Sep; 15(5):439-42.
    View in: PubMed
    Score: 0.011
  36. Prevention of venous thromboembolism in the plastic surgery patient: current guidelines and recommendations. Aesthet Surg J. 2009 Sep-Oct; 29(5):421-8.
    View in: PubMed
    Score: 0.011
  37. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations. Ann Surg. 2009 Aug; 250(2):219-28.
    View in: PubMed
    Score: 0.011
  38. Implications of thromboprophylaxis registry data on clinical practice. Am J Med Sci. 2009 Jul; 338(1):58-63.
    View in: PubMed
    Score: 0.011
  39. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga. Thromb Haemost. 2008 Jun; 99(6):993-4.
    View in: PubMed
    Score: 0.010
  40. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9.
    View in: PubMed
    Score: 0.010
  41. The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options. J Surg Oncol. 2007 Sep 01; 96(3):265-72.
    View in: PubMed
    Score: 0.010
  42. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med. 2007 Jun; 131(6):872-84.
    View in: PubMed
    Score: 0.010
  43. Compliance with antithrombotic guidelines. Manag Care. 2006 Sep; 15(9):49-50, 53-60, 66.
    View in: PubMed
    Score: 0.009
  44. Venous thromboembolism following major orthopedic surgery: what is the risk after discharge? Orthopedics. 2006 06; 29(6):506-16.
    View in: PubMed
    Score: 0.009
  45. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. J Vasc Surg. 2005 Oct; 42(4):726-33.
    View in: PubMed
    Score: 0.008
  46. Thrombophilia testing in patients with venous thrombosis. Eur J Vasc Endovasc Surg. 2005 Nov; 30(5):550-5.
    View in: PubMed
    Score: 0.008
  47. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005 Feb-Mar; 51(2-3):70-8.
    View in: PubMed
    Score: 0.008
  48. Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 2004 Mar 30; 109(12 Suppl 1):I4-8.
    View in: PubMed
    Score: 0.008
  49. Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence. Int Angiol. 2024 Feb; 43(1):1-222.
    View in: PubMed
    Score: 0.008
  50. Deep vein thrombosis: validation of a patient-reported leg symptom index. Health Qual Life Outcomes. 2003 Dec 15; 1:76.
    View in: PubMed
    Score: 0.007
  51. Calf deep venous thrombosis should be treated with anticoagulation. Med Clin North Am. 2003 Nov; 87(6):1157-64.
    View in: PubMed
    Score: 0.007
  52. Fake-news-free evidence-based communication for proper vein-lymphatic disease management. Int Angiol. 2023 Apr; 42(2):89-189.
    View in: PubMed
    Score: 0.007
  53. Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023. Phlebology. 2023 May; 38(4):205-258.
    View in: PubMed
    Score: 0.007
  54. Using the Caprini Risk Score to Increase Awareness of Venous Thrombus Embolism in the Community: Know Your Score II. Clin Appl Thromb Hemost. 2023 Jan-Dec; 29:10760296231188425.
    View in: PubMed
    Score: 0.007
  55. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health. 2003 Jan-Feb; 6(1):59-74.
    View in: PubMed
    Score: 0.007
  56. Thrombosis prophylaxis in surgical patients using the Caprini Risk Score. Curr Probl Surg. 2022 11; 59(11):101221.
    View in: PubMed
    Score: 0.007
  57. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States. Int Angiol. 2002 Mar; 21(1):78-85.
    View in: PubMed
    Score: 0.007
  58. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. Cochrane Database Syst Rev. 2022 01 28; 1:CD005258.
    View in: PubMed
    Score: 0.007
  59. Thrombosis prophylaxis in orthopedic surgery: current clinical considerations. J South Orthop Assoc. 2002; 11(4):190-6.
    View in: PubMed
    Score: 0.007
  60. A Prospective Study Evaluating Patterns of Responses to the Caprini Score to Prevent Venous Thromboembolism After Interventional Treatment for Varicose Veins. Clin Appl Thromb Hemost. 2022 Jan-Dec; 28:10760296221112081.
    View in: PubMed
    Score: 0.007
  61. Home use of impulse compression of the foot and compression stockings in the treatment of chronic venous insufficiency. J Vasc Surg. 2001 Nov; 34(5):805-11.
    View in: PubMed
    Score: 0.006
  62. Thromboprophylaxis; what is the future, for high risk surgical patients? Phlebology. 2022 03; 37(2):81-83.
    View in: PubMed
    Score: 0.006
  63. Evaluation of oxygen extraction ratio as a physiologic transfusion trigger in coronary artery bypass graft surgery patients. Transfusion. 2001 May; 41(5):591-5.
    View in: PubMed
    Score: 0.006
  64. Air travel-related deep venous thrombosis. Chicago views. Cardiovasc Surg. 2001 Apr; 9(2):150-3; discussion 153-6.
    View in: PubMed
    Score: 0.006
  65. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol. 2001 Apr; 38(2 Suppl 5):12-9.
    View in: PubMed
    Score: 0.006
  66. Timing and characteristics of venous thromboembolism after noncancer surgery. J Vasc Surg Venous Lymphat Disord. 2021 07; 9(4):859-867.e2.
    View in: PubMed
    Score: 0.006
  67. Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study. J Am Heart Assoc. 2020 10 20; 9(19):e017316.
    View in: PubMed
    Score: 0.006
  68. Response to letter to editor regarding: "Risks and contraindications of medical compression treatment - a critical reappraisal. An international consensus statement PHLEB-19-150.R1". Phlebology. 2020 12; 35(10):838-839.
    View in: PubMed
    Score: 0.006
  69. Finding the right fit: effective thrombosis risk stratification in orthopedic patients. Orthopedics. 2000 Jun; 23(6 Suppl):s633-8.
    View in: PubMed
    Score: 0.006
  70. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
    View in: PubMed
    Score: 0.006
  71. Risks and contraindications of medical compression treatment - A critical reappraisal. An international consensus statement. Phlebology. 2020 Aug; 35(7):447-460.
    View in: PubMed
    Score: 0.006
  72. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620936350.
    View in: PubMed
    Score: 0.006
  73. Clinical Validation of the Chinese Version of Patient Completed Caprini Risk Assessment Form. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620945038.
    View in: PubMed
    Score: 0.006
  74. Deep vein thrombosis outcome and the level of oral anticoagulation therapy. J Vasc Surg. 1999 Nov; 30(5):805-11.
    View in: PubMed
    Score: 0.006
  75. The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement. J Vasc Surg. 1999 Nov; 30(5):813-20.
    View in: PubMed
    Score: 0.006
  76. Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk. J Thromb Haemost. 2019 11; 17(11):1966-1972.
    View in: PubMed
    Score: 0.006
  77. Matching risk with treatment strategies in deep vein thrombosis management. Blood Coagul Fibrinolysis. 1999 Aug; 10 Suppl 2:S37-43.
    View in: PubMed
    Score: 0.006
  78. Assessment of coagulation system activation using spot urine measurements. Blood Coagul Fibrinolysis. 1999 Jul; 10(5):285-9.
    View in: PubMed
    Score: 0.005
  79. Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database. Int Angiol. 2019 Jun; 38(3):173-184.
    View in: PubMed
    Score: 0.005
  80. Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology. J Vasc Surg Venous Lymphat Disord. 2019 01; 7(1):17-28.
    View in: PubMed
    Score: 0.005
  81. Risk Assessment in Chinese Hospitalized Patients Comparing the Padua and Caprini Scoring Algorithms. Clin Appl Thromb Hemost. 2018 Dec; 24(9_suppl):127S-135S.
    View in: PubMed
    Score: 0.005
  82. The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thromb Haemost. 2017 12; 117(12):2415-2424.
    View in: PubMed
    Score: 0.005
  83. Predictors of active cancer thromboembolic outcomes: mortality associated with calf deep vein thrombosis. Int Angiol. 2017 Dec; 36(6):553-557.
    View in: PubMed
    Score: 0.005
  84. Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis. Thromb Haemost. 2017 06 02; 117(6):1192-1198.
    View in: PubMed
    Score: 0.005
  85. The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patients. Am J Obstet Gynecol. 2017 03; 216(3):326.
    View in: PubMed
    Score: 0.005
  86. Comparisons Between Upper and Lower Extremity Deep Vein Thrombosis: A Review of the RIETE Registry. Clin Appl Thromb Hemost. 2017 Oct; 23(7):748-754.
    View in: PubMed
    Score: 0.005
  87. Venous hemodynamic changes in lower limb venous disease: the UIP consensus according to scientific evidence. Int Angiol. 2016 06; 35(3):236-352.
    View in: PubMed
    Score: 0.004
  88. Development of a Novel Composite Process Measure for Venous Thromboembolism Prophylaxis. Med Care. 2016 Feb; 54(2):210-7.
    View in: PubMed
    Score: 0.004
  89. Patterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol. J Am Coll Surg. 2016 06; 222(6):1074-80.
    View in: PubMed
    Score: 0.004
  90. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med. 2015 Aug 27; 373(9):823-33.
    View in: PubMed
    Score: 0.004
  91. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis. J Vasc Surg Venous Lymphat Disord. 2015 Jul; 3(3):243-50.e1.
    View in: PubMed
    Score: 0.004
  92. The ultrasonic localization of abdominal wall adhesions. Surg Endosc. 1995 Mar; 9(3):283-5.
    View in: PubMed
    Score: 0.004
  93. Postoperative hypercoagulability and deep-vein thrombosis after laparoscopic cholecystectomy. Surg Endosc. 1995 Mar; 9(3):304-9.
    View in: PubMed
    Score: 0.004
  94. Venous duplex imaging follow-up of acute symptomatic deep vein thrombosis of the leg. J Vasc Surg. 1995 Mar; 21(3):472-6.
    View in: PubMed
    Score: 0.004
  95. Thromboelastography: measuring statistical probabilities. Semin Thromb Hemost. 1995; 21 Suppl 4:14-20.
    View in: PubMed
    Score: 0.004
  96. Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine. Semin Thromb Hemost. 1995; 21 Suppl 4:59-62.
    View in: PubMed
    Score: 0.004
  97. Perspectives on thromboelastography. Semin Thromb Hemost. 1995; 21 Suppl 4:91-3.
    View in: PubMed
    Score: 0.004
  98. Prevention of venous thromboembolism in North America: results of a survey among general surgeons. J Vasc Surg. 1994 Nov; 20(5):751-8.
    View in: PubMed
    Score: 0.004
  99. Compression stockings to prevent post-thrombotic syndrome. Lancet. 2014 Jul 12; 384(9938):129-30.
    View in: PubMed
    Score: 0.004
  100. Prevention of postoperative venous thromboembolism following laparoscopic cholecystectomy. Surg Endosc. 1994 Jul; 8(7):741-7.
    View in: PubMed
    Score: 0.004
  101. Adaptive compression therapy for venous leg ulcers: a clinically effective, patient-centred approach. Int Wound J. 2016 Jun; 13(3):317-25.
    View in: PubMed
    Score: 0.004
  102. Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry. Clin Appl Thromb Hemost. 2014 Nov; 20(8):772-8.
    View in: PubMed
    Score: 0.004
  103. Cost-effective laparoscopic cholangiography. Surg Laparosc Endosc. 1994 Apr; 4(2):142-5.
    View in: PubMed
    Score: 0.004
  104. Prevention and treatment of venous thromboembolism--International Consensus Statement. Int Angiol. 2013 Apr; 32(2):111-260.
    View in: PubMed
    Score: 0.004
  105. Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials. Thromb Res. 2012 Sep; 130(3):396-402.
    View in: PubMed
    Score: 0.003
  106. Low molecular weight heparins and external pneumatic compression as options for venous thromboembolism prophylaxis: a surgeon's perspective. Semin Thromb Hemost. 1991 Oct; 17(4):356-66.
    View in: PubMed
    Score: 0.003
  107. Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg. 2011 Jul; 254(1):131-7.
    View in: PubMed
    Score: 0.003
  108. Iatrogenic biliary tract complications: radiologic features and clinical significance. Radiographics. 1991 May; 11(3):441-56.
    View in: PubMed
    Score: 0.003
  109. Can combined (mechanical and pharmacological) modalities prevent fatal VTE? Int Angiol. 2011 Apr; 30(2):115-22.
    View in: PubMed
    Score: 0.003
  110. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991; 17 Suppl 3:304-12.
    View in: PubMed
    Score: 0.003
  111. Prevention and treatment of the postthrombotic syndrome. J Vasc Surg. 2010 Nov; 52(5 Suppl):21S-28S.
    View in: PubMed
    Score: 0.003
  112. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res. 2010 Sep; 126(3):175-82.
    View in: PubMed
    Score: 0.003
  113. Postoperative deep vein thrombosis: current clinical considerations. Semin Thromb Hemost. 1989 Jul; 15(3):244-9.
    View in: PubMed
    Score: 0.003
  114. Call to action to prevent venous thromboembolism. J Vasc Surg. 2009 Jun; 49(6):1620-3.
    View in: PubMed
    Score: 0.003
  115. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thrombo-embolism in high-risk patients. Eur J Vasc Endovasc Surg. 2009 Mar; 37(3):364-5.
    View in: PubMed
    Score: 0.003
  116. Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis. Thromb Haemost. 2009 Jan; 101(1):77-85.
    View in: PubMed
    Score: 0.003
  117. In brief. Thromboembolic disease. Curr Probl Surg. 2008 Dec; 45(12):838-42.
    View in: PubMed
    Score: 0.003
  118. Thromboembolic diseases. Curr Probl Surg. 2008 Dec; 45(12):844-99.
    View in: PubMed
    Score: 0.003
  119. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev. 2008 Oct 08; (4):CD005258.
    View in: PubMed
    Score: 0.003
  120. Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program. J Vasc Surg. 2008 Aug; 48(2):394-9.
    View in: PubMed
    Score: 0.003
  121. Biliary stone extraction. Am Surg. 1988 Jun; 54(6):343-6.
    View in: PubMed
    Score: 0.003
  122. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry. Thromb Haemost. 2008 Mar; 99(3):546-51.
    View in: PubMed
    Score: 0.003
  123. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost. 1988 Feb 25; 59(1):62-7.
    View in: PubMed
    Score: 0.003
  124. Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use. Int Angiol. 2008 Feb; 27(1):60-7.
    View in: PubMed
    Score: 0.002
  125. Role of compression modalities in a prophylactic program for deep vein thrombosis. Semin Thromb Hemost. 1988; 14 Suppl:77-87.
    View in: PubMed
    Score: 0.002
  126. Acute venous disease: venous thrombosis and venous trauma. J Vasc Surg. 2007 Dec; 46 Suppl S:25S-53S.
    View in: PubMed
    Score: 0.002
  127. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007 Sep; 5(9):1854-61.
    View in: PubMed
    Score: 0.002
  128. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience. Radiology. 2007 Mar; 242(3):873-81.
    View in: PubMed
    Score: 0.002
  129. Venous thromboembolism and cancer. Curr Probl Surg. 2007 Mar; 44(3):157-216.
    View in: PubMed
    Score: 0.002
  130. Results of the national pilot screening program for venous disease by the American Venous Forum. J Vasc Surg. 2007 Jan; 45(1):142-148.
    View in: PubMed
    Score: 0.002
  131. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses. Thromb Haemost. 1986 Aug 20; 56(1):71-9.
    View in: PubMed
    Score: 0.002
  132. Measurement of lower leg compression in vivo: recommendations for the performance of measurements of interface pressure and stiffness: consensus statement. Dermatol Surg. 2006 Feb; 32(2):224-32; discussion 233.
    View in: PubMed
    Score: 0.002
  133. Novel in vitro perfusion model to study the interaction between coagulation and blood-borne metastasis. J Cell Biochem. 2005 Nov 01; 96(4):700-8.
    View in: PubMed
    Score: 0.002
  134. Etiology, diagnosis, and treatment of recovery room bleeding/hemorrhage. Heart Lung. 1985 Nov; 14(6):556-61.
    View in: PubMed
    Score: 0.002
  135. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med. 2005 Jul 11; 165(13):1458-64.
    View in: PubMed
    Score: 0.002
  136. Fatal vascular outcomes following major orthopedic surgery. Thromb Haemost. 2005 May; 93(5):860-6.
    View in: PubMed
    Score: 0.002
  137. A new forceps for removal of biliary tract stones. Surg Gynecol Obstet. 1985 Apr; 160(4):360-1.
    View in: PubMed
    Score: 0.002
  138. Air travel-related venous thromboembolism. Dis Mon. 2005 Feb-Mar; 51(2-3):200-7.
    View in: PubMed
    Score: 0.002
  139. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost. 2004 Nov; 2(11):1892-8.
    View in: PubMed
    Score: 0.002
  140. The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients. J Vasc Surg. 2003 Nov; 38(5):916-22.
    View in: PubMed
    Score: 0.002
  141. Thrombosis prophylaxis using external compression. Surg Gynecol Obstet. 1983 May; 156(5):599-604.
    View in: PubMed
    Score: 0.002
  142. Laboratory monitoring of continuous intravenous heparin therapy. Thromb Res. 1983 Jan 01; 29(1):91-4.
    View in: PubMed
    Score: 0.002
  143. Correlates of thrombin generation in patients with advanced prostate cancer. Thromb Haemost. 2003 Jan; 89(1):185-9.
    View in: PubMed
    Score: 0.002
  144. Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States. Clin Ther. 2002 Nov; 24(11):1960-86; discussion 1938.
    View in: PubMed
    Score: 0.002
  145. Altered coagulability in cancer patients. CA Cancer J Clin. 1982 May-Jun; 32(3):162-72.
    View in: PubMed
    Score: 0.002
  146. Comparison of thrombelastography with common coagulation tests. Thromb Haemost. 1981 Dec 23; 46(4):752-6.
    View in: PubMed
    Score: 0.002
  147. Gallbladder disease: current trends and treatments. Am J Nurs. 1980 Dec; 80(12):2181-5.
    View in: PubMed
    Score: 0.002
  148. Results of nonsurgical treatment of retained biliary calculi. Surg Gynecol Obstet. 1980 Nov; 151(5):630-4.
    View in: PubMed
    Score: 0.002
  149. Adjuvant chemotherapy for stage II and III breast carcinoma. JAMA. 1980 Jul 18; 244(3):243-6.
    View in: PubMed
    Score: 0.001
  150. A guide to venous thromboembolism risk factor assessment. J Thromb Thrombolysis. 2000 Apr; 9(3):253-62.
    View in: PubMed
    Score: 0.001
  151. Risk factor assessment in the management of patients with suspected deep venous thrombosis. Int Angiol. 2000 Mar; 19(1):47-51.
    View in: PubMed
    Score: 0.001
  152. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med. 2000 Feb 14; 160(3):334-40.
    View in: PubMed
    Score: 0.001
  153. The use of a Bayesian forecasting model in the management of warfarin therapy after total hip arthroplasty. J Arthroplasty. 1999 Dec; 14(8):988-93.
    View in: PubMed
    Score: 0.001
  154. Altered coagulability in malignancy. IMJ Ill Med J. 1979 Nov; 156(5):384-90.
    View in: PubMed
    Score: 0.001
  155. Nonsurgical diagnosis and management of puerperal ovarian vein thrombophlebitis. Am J Obstet Gynecol. 1979 Feb 15; 133(4):461-3.
    View in: PubMed
    Score: 0.001
  156. Evaluation of therapeutic compression stockings in the treatment of chronic venous insufficiency. Dermatol Surg. 1999 Feb; 25(2):116-20.
    View in: PubMed
    Score: 0.001
  157. Viscoelastic effects of dextran 70 on human blood. Surg Forum. 1979; 30:491-3.
    View in: PubMed
    Score: 0.001
  158. Use of progressive pneumoperitoneum in the treatment of giant abdominal hernias. Am Surg. 1978 Jun; 44(6):337-41.
    View in: PubMed
    Score: 0.001
  159. Hematologic changes following burns. J Surg Res. 1977 Jun; 22(6):626-35.
    View in: PubMed
    Score: 0.001
  160. Percutaneous forceps extraction of retained biliary tract calculi. Gastrointest Radiol. 1977 May 25; 1(4):319-24.
    View in: PubMed
    Score: 0.001
  161. Heparin therapy-part I. Cardiovasc Nurs. 1977 May-Jun; 13(3):13-6.
    View in: PubMed
    Score: 0.001
  162. Volvulus of the small bowel: an uncommon complication after laparoscopic cholecystectomy. J Laparoendosc Adv Surg Tech A. 1997 Feb; 7(1):59-62.
    View in: PubMed
    Score: 0.001
  163. The identification of accelerated coagulability. Thromb Res. 1976 Aug; 9(2):167-80.
    View in: PubMed
    Score: 0.001
  164. Nonoperative extraction of retained common duct stones. Arch Surg. 1976 Apr; 111(4):445-5.
    View in: PubMed
    Score: 0.001
  165. Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: preliminary results. J Vasc Surg. 1996 Apr; 23(4):616-21.
    View in: PubMed
    Score: 0.001
  166. Modifications of plasma levels of tissue factor pathway inhibitor and endothelin-1 induced by a reverse Trendelenburg position: influence of elastic compression--preliminary results. J Vasc Surg. 1995 Nov; 22(5):568-72.
    View in: PubMed
    Score: 0.001
  167. The haemostatic effectiveness of autologous platelet rich plasma sequestered after heparin administration and institution of cardiopulmonary bypass. Perfusion. 1995 Mar; 10(2):101-10.
    View in: PubMed
    Score: 0.001
  168. Modified radical mastectomy. Cancer. 1975 Mar; 35(3):710-3.
    View in: PubMed
    Score: 0.001
  169. The normal thromboelastogram and its interpretation. Semin Thromb Hemost. 1995; 21 Suppl 4:7-13.
    View in: PubMed
    Score: 0.001
  170. Thromboelastography for the assessment of hypercoagulability during general surgery. Semin Thromb Hemost. 1995; 21 Suppl 4:21-6.
    View in: PubMed
    Score: 0.001
  171. Application of thromboelastography in other medical and surgical states. Semin Thromb Hemost. 1995; 21 Suppl 4:50-2.
    View in: PubMed
    Score: 0.001
  172. Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration. Semin Thromb Hemost. 1995; 21 Suppl 4:53-8.
    View in: PubMed
    Score: 0.001
  173. Contact activation of heparinized plasma. Thromb Res. 1974 Sep; 5(3):379-400.
    View in: PubMed
    Score: 0.001
  174. Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution. Thromb Res. 1974 Feb; 4(2):199-217.
    View in: PubMed
    Score: 0.001
  175. Venous thromboembolism after hospital discharge. Semin Thromb Hemost. 1993; 19 Suppl 1:142-6.
    View in: PubMed
    Score: 0.001
  176. Diagnosis and treatment of common bleeding disorders. IMJ Ill Med J. 1972 Dec; 142(6):564-8 passim.
    View in: PubMed
    Score: 0.001
  177. Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK. Int Angiol. 1992 Jul-Sep; 11(3):151-9.
    View in: PubMed
    Score: 0.001
  178. Coagulation changes in acutely bleeding patients. Arch Surg. 1972 Apr; 104(4):559-64.
    View in: PubMed
    Score: 0.001
  179. Coagulation changes in acutely bleeding patients. Proc Inst Med Chic. 1972 Mar; 29(2):82.
    View in: PubMed
    Score: 0.001
  180. The effect of intravenous fixed-dose heparin during total hip arthroplasty on the incidence of deep-vein thrombosis. A randomized, double-blind trial in patients operated on with epidural anesthesia and controlled hypotension. J Bone Joint Surg Am. 1991 Dec; 73(10):1575-6.
    View in: PubMed
    Score: 0.001
  181. International perspective on venous thromboembolism prophylaxis in surgery. Semin Thromb Hemost. 1991 Oct; 17(4):322-5.
    View in: PubMed
    Score: 0.001
  182. Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost. 1991; 17 Suppl 3:313-8.
    View in: PubMed
    Score: 0.001
  183. Relationship between postsurgical fibrinolytic parameters and deep vein thrombosis in surgical patients treated with compression devices. Am Surg. 1988 Mar; 54(3):156-60.
    View in: PubMed
    Score: 0.001
  184. Thrombelastography of blood from subjects with chronic renal failure. Thromb Res. 1987 Mar 15; 45(6):817-25.
    View in: PubMed
    Score: 0.001
  185. Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy. J Surg Oncol. 1984 Aug; 26(4):233-7.
    View in: PubMed
    Score: 0.000
  186. Omental anisakiasis: a rare mimic of acute appendicitis. Am J Clin Pathol. 1983 Oct; 80(4):517-20.
    View in: PubMed
    Score: 0.000
  187. Follow-up adjuvant chemotherapy and chemoimmunotherapy for stage II and III carcinoma of the breast. Cancer. 1982 May 01; 49(9):1754-61.
    View in: PubMed
    Score: 0.000
  188. Preoperative and follow-up procedures on patients with breast cancer. Cancer. 1980 Aug 15; 46(4 Suppl):977-9.
    View in: PubMed
    Score: 0.000
  189. Coagulation changes in the newborn with respiratory failure. Thromb Res. 1980 Jan 1-15; 17(1-2):153-75.
    View in: PubMed
    Score: 0.000
  190. Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer. 1979 Mar; 43(3):956-60.
    View in: PubMed
    Score: 0.000
  191. Multi system analysis of intravenous calcium and sodium heparin. Thromb Res. 1979; 14(6):881-900.
    View in: PubMed
    Score: 0.000
  192. Disseminated intravascular multiple systems activation (DIMSA) following thermal injury. J Trauma. 1978 Jun; 18(6):432-9.
    View in: PubMed
    Score: 0.000
  193. Evaluation of three methods used to identify accelerated coagulability. Thromb Res. 1977 Apr; 10(4):587-604.
    View in: PubMed
    Score: 0.000
  194. Unusual popliteal mass. IMJ Ill Med J. 1977 Feb; 151(2):117-20.
    View in: PubMed
    Score: 0.000
  195. Unusual popleteal mass. IMJ Ill Med J. 1977 Feb; 151(2):117-20.
    View in: PubMed
    Score: 0.000
  196. An unusual complication of minidose heparin therapy. Clin Orthop Relat Res. 1976 Jul-Aug; (118):130-2.
    View in: PubMed
    Score: 0.000
  197. In vitro testing of surface thrombogenicity using the thrombelastograph. Res Commun Chem Pathol Pharmacol. 1976 Mar; 13(3):507-19.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.